Hematopoietic stem cell transplantation (HSCT) is a highly effective and unique medical
procedure for the treatment of most hematological malignancies. The first allogeneic …

Haploidentical donor stem cell transplantation (haplo-SCT) has made great advances in
recent decades. The granulocyte colony-stimulating factor (G-CSF)-and antithymocyte …

Cell therapies and regenerative medicine interventions require an adequate source of
therapeutic cells. Here, we demonstrate that constructing in vivo osteo-organoids by …

One of the most complex issues with haploidentical stem cell transplantation (haplo‐SCT) is
donor selection, given that multiple haploidentical donors are often available for a given …

Maternal and collateral donors were associated with a higher incidence of graft-versus-host
disease (GvHD) after haploidentical hematopoietic stem cell transplantation (haplo-HSCT) …

Gonadotropin-releasing hormone agonist (GnRHa) appears to exhibit ovarian protection
during chemotherapy for malignant tumors. The purpose of this study was to analyze the …

G-CSF-mobilized peripheral blood (G-PB) harvest is the predominant graft for identical
sibling donor and unrelated donor allogeneic hematopoietic stem cell transplantation …

Background The role of allogeneic hematopoietic stem cell transplantation (allo‐HSCT) in
patients< 3 years of age remains controversial. Data on haploidentical donor (HID) …

Clinical data of patients with severe aplastic anemia (SAA) were retrospectively analyzed to
evaluate the outcomes of haploidentical hematopoietic stem cell transplantation (HID-HSCT) …

Posterior reversible encephalopathy syndrome (PRES) is a gradually recognised
neurological complication of allogenic haematopoietic stem cell transplantation (allo-HSCT) …